NIH develops AI agent to improve accuracy of gene set analysis
The system, called GeneAgent, cross-checks its own initial predictions for accuracy against information from established, expert-curated databases
The system, called GeneAgent, cross-checks its own initial predictions for accuracy against information from established, expert-curated databases
The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of 2026
The company’s largest center for medical device applications, serving the entire Asian market
Takara Bio Europe will distribute MN’s Bioanalysis portfolio in Austria, Belgium, Denmark, France, Germany, Ireland, Luxembourg, Sweden, Switzerland, and the United Kingdom
The approval is based on a comprehensive package of analytical, nonclinical, and clinical data
The CR Bio unit represents a non-core legacy asset with limited strategic alignment to our core CDMO operations
BASF strengthens its commitment to the biopharma and pharmaceutical ingredients industries through a new investment in North America
Integrated facility to deliver end-to-end, customized workflows across life sciences, diagnostics, and applied markets
Investment demonstrates confidence in America’s commitment to science and innovation
Subscribe To Our Newsletter & Stay Updated